IMUNON enters CRADA with National Cancer Institute for IMNN-001
IMUNON said it entered a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute to advance clinical development of IMNN-001.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.